Author:
Chen Lu,Xiong Haijuan,Wen Qiaorui,Lv Jun,Sun Dianjianyi,Pei Pei,Yang Ling,Chen Yiping,Du Huaidong,Li Lihui,Yang Xiaoming,Avery Daniel,Chen Junshi,Chen Zhengming,Li Liming,Yu Canqing,
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Disease GIfCOL: Global strategy for the diagnosis, management, and prevention of COPD: 2023 report. In.; 2022.
2. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58.
3. Ge J, Xu Y, Wang C. Internal Medicine (9th edition). Beijing: People’s Medical Publishing House; 2018.
4. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.
5. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of “overspill” of inflammatory mediators from the lungs? Review Evidence Thorax. 2010;65(10):930–6.